Bank of New York Mellon’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.95M | Buy |
194,101
+20,215
| +12% | +$411K | ﹤0.01% | 2396 |
|
2025
Q1 | $3.16M | Sell |
173,886
-7,724
| -4% | -$140K | ﹤0.01% | 2437 |
|
2024
Q4 | $4.59M | Buy |
181,610
+410
| +0.2% | +$10.4K | ﹤0.01% | 2330 |
|
2024
Q3 | $6.16M | Sell |
181,200
-48,962
| -21% | -$1.66M | ﹤0.01% | 2187 |
|
2024
Q2 | $8.52M | Buy |
230,162
+29,324
| +15% | +$1.09M | ﹤0.01% | 2046 |
|
2024
Q1 | $8.43M | Buy |
200,838
+31,699
| +19% | +$1.33M | ﹤0.01% | 2041 |
|
2023
Q4 | $6.71M | Buy |
169,139
+4,982
| +3% | +$198K | ﹤0.01% | 2220 |
|
2023
Q3 | $4.52M | Buy |
164,157
+2,408
| +1% | +$66.3K | ﹤0.01% | 2367 |
|
2023
Q2 | $5.49M | Sell |
161,749
-3,319
| -2% | -$113K | ﹤0.01% | 2273 |
|
2023
Q1 | $5.94M | Sell |
165,068
-3,921
| -2% | -$141K | ﹤0.01% | 2204 |
|
2022
Q4 | $7.53M | Buy |
168,989
+6,207
| +4% | +$277K | ﹤0.01% | 2097 |
|
2022
Q3 | $4.58M | Buy |
162,782
+13,197
| +9% | +$371K | ﹤0.01% | 2332 |
|
2022
Q2 | $4.03M | Sell |
149,585
-4,118
| -3% | -$111K | ﹤0.01% | 2432 |
|
2022
Q1 | $5.24M | Buy |
153,703
+243
| +0.2% | +$8.28K | ﹤0.01% | 2396 |
|
2021
Q4 | $5.93M | Sell |
153,460
-19,286
| -11% | -$745K | ﹤0.01% | 2371 |
|
2021
Q3 | $9.33M | Buy |
172,746
+56,311
| +48% | +$3.04M | ﹤0.01% | 2156 |
|
2021
Q2 | $3.89M | Buy |
116,435
+67,182
| +136% | +$2.25M | ﹤0.01% | 2609 |
|
2021
Q1 | $1.02M | Sell |
49,253
-2,285
| -4% | -$47.1K | ﹤0.01% | 3319 |
|
2020
Q4 | $903K | Buy |
51,538
+32,689
| +173% | +$573K | ﹤0.01% | 3310 |
|
2020
Q3 | $280K | Buy |
+18,849
| New | +$280K | ﹤0.01% | 3744 |
|
2019
Q2 | – | Sell |
-25,521
| Closed | -$126K | – | 4213 |
|
2019
Q1 | $126K | Buy |
25,521
+19,799
| +346% | +$97.8K | ﹤0.01% | 3958 |
|
2018
Q4 | $17K | Sell |
5,722
-20
| -0.3% | -$59 | ﹤0.01% | 4166 |
|
2018
Q3 | $39K | Buy |
5,742
+20
| +0.3% | +$136 | ﹤0.01% | 4141 |
|
2018
Q2 | $43K | Sell |
5,722
-38,295
| -87% | -$288K | ﹤0.01% | 4103 |
|
2018
Q1 | $1.54M | Sell |
44,017
-2,025
| -4% | -$70.8K | ﹤0.01% | 2960 |
|
2017
Q4 | $1.96M | Buy |
46,042
+4,547
| +11% | +$194K | ﹤0.01% | 2843 |
|
2017
Q3 | $1.78M | Buy |
41,495
+1,460
| +4% | +$62.6K | ﹤0.01% | 2900 |
|
2017
Q2 | $1.48M | Buy |
40,035
+4,158
| +12% | +$154K | ﹤0.01% | 3021 |
|
2017
Q1 | $1.94M | Buy |
35,877
+374
| +1% | +$20.3K | ﹤0.01% | 2869 |
|
2016
Q4 | $1.89M | Buy |
35,503
+6,905
| +24% | +$367K | ﹤0.01% | 2887 |
|
2016
Q3 | $1.73M | Sell |
28,598
-1,451
| -5% | -$87.9K | ﹤0.01% | 2846 |
|
2016
Q2 | $1.98M | Sell |
30,049
-1,100
| -4% | -$72.4K | ﹤0.01% | 2713 |
|
2016
Q1 | $1.77M | Sell |
31,149
-50
| -0.2% | -$2.84K | ﹤0.01% | 2730 |
|
2015
Q4 | $7.34M | Buy |
31,199
+250
| +0.8% | +$58.8K | ﹤0.01% | 1999 |
|
2015
Q3 | $4.89M | Sell |
30,949
-74,810
| -71% | -$11.8M | ﹤0.01% | 2241 |
|
2015
Q2 | $40M | Buy |
105,759
+4,764
| +5% | +$1.8M | 0.01% | 1035 |
|
2015
Q1 | $42.2M | Sell |
100,995
-65,809
| -39% | -$27.5M | 0.01% | 1001 |
|
2014
Q4 | $45.7M | Buy |
166,804
+13,393
| +9% | +$3.67M | 0.01% | 939 |
|
2014
Q3 | $29.8M | Buy |
153,411
+1,458
| +1% | +$283K | 0.01% | 1172 |
|
2014
Q2 | $37.2M | Buy |
151,953
+121,290
| +396% | +$29.7M | 0.01% | 1072 |
|
2014
Q1 | $8.13M | Sell |
30,663
-3,205
| -9% | -$849K | ﹤0.01% | 2030 |
|
2013
Q4 | $12.3M | Buy |
33,868
+1,910
| +6% | +$694K | ﹤0.01% | 1754 |
|
2013
Q3 | $17M | Buy |
31,958
+3,338
| +12% | +$1.77M | 0.01% | 1504 |
|
2013
Q2 | $6.7M | Buy |
+28,620
| New | +$6.7M | ﹤0.01% | 2023 |
|